PRLD stock

Prelude Therapeutics Inc (PRLD) financials · rev $12.1M

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Prelude Therapeutics Inc (PRLD) rev $12.1M.

Cached annual income statement
LineFY2025FY2024
Revenue$12.1M$7.00M
Operating Income-$104.6M-$139.7M
Net Income-$99.5M-$127.2M
EPS (Diluted)-$1.29-$1.68
Cached annual balance sheet
LineFY2025FY2024
Total Assets$141.3M$175.5M
Current Assets$105.7M$135.9M
Cash & Equivalents$35.3M$12.5M
PP&E$5.11M$6.77M
Total Liabilities$72.7M$44.1M
Current Liabilities$53.0M$25.6M
Shareholders' Equity$68.6M$131.5M
Retained Earnings-$683.1M-$583.6M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$56.3M-$102.9M
CapEx$67.0K$764.0K
Investing Cash Flow$53.5M$90.2M
Financing Cash Flow$24.8M-$120.0K
Net Change in Cash$22.0M-$12.8M
Free Cash Flow-$56.4M-$103.7M
These statements as JSON? API free 100/day

FAQ

What is PRLD P/E and revenue?

Prelude Therapeutics Inc (PRLD) rev $12.1M.

What is PRLD revenue?

Prelude Therapeutics Inc last cached revenue is $12.1M (FY2025).

Is PRLD profitable?

Prelude Therapeutics Inc last cached net income is -$99.5M (FY2025).

What are PRLD total assets?

Prelude Therapeutics Inc last cached total assets are $141.3M (FY2025).

What is PRLD free cash flow?

Prelude Therapeutics Inc last cached free cash flow is -$56.4M (FY2025).

Not investment advice. Cached statements, not a live tape.